Silver sulfadiazine (AgSu) was found to interact with isolated deoxyribonucleic acid (DNA) to form nondissociable complexes. These complexes differ in physical and chemical properties from those that are established when silver nitrate is added to DNA. The reaction between AgSu and DNA is visualized as occurring in two stages: (i) a weak and reversible interaction (intercalation) between DNA and the sulfadiazine moiety and (ii) a tight binding involving the silver atom. In the first stage, sodium sulfadiazine competes with AgSu for the DNA.Silver sulfadiazine (AgSu) was synthesized by Fox, who also established its effectiveness for the prevention and treatment of burn infections due to pseudomonads (8)(9)(10)28). Even though AgSu is a sulfonamide drug, its antibacterial activity is not a function of the sulfonamide moiety because its effectiveness is not reversed by p-aminobenzoic acid (10). Silver nitrate (AgNO3) reacts with deoxyribonucleic acid (DNA) in vitro (14, 31; see also 3 and 33); hence, it has been suggested (10) that AgSu reacts with the cellular DNA and that this forms the basis of its antibacterial action. It has been proposed further (10) that when AgSu reacts with the cellular DNA it dissociates and that only the silver ion becomes associated with DNA while the sulfadiazine portion is released. However, data on both the in vivo and in vitro effects of AgSu are scarce, and therefore an examination of its mode of action was undertaken. The present study shows that in vitro AgSu forms a complex with DNA which is unlike that formed when DNA is mixed with AgNO3; but it is also shown (25; (20), and bacteriophage DNA was isolated from Klebsiella phage E-1, currently under investigation in this laboratory. 3H-labeled DNA derived from chicken embryos was prepared as described previously (13). All DNA specimens were dissolved in 0.005 M NaNO3 and extensively dialyzed against 0.005 M NaNO3 to remove all traces of chloride (capable of reacting with AgNO3 to form AgCl).JSulfadiazines. AgSu (29.1% silver) and sodium sulfadiazine (NaSu) were generously provided by Marion Laboratories, Inc., Kansas City, Mo. Only freshly prepared solutions (in 0.005 M NaNO3) were used.Chemical analysis. The phosphorus content of DNA specimens was determined by the procedure of Fiske and Subbarow (7).Spectral analysis. The spectra of DNA solutions were taken with a Carey model 11 recording spectrophotometer, and the absorbance at selected wavelengths was checked with a Beckman DU-2 spectrophotometer.Centrifugal procedures. Sedimentation velocity studies were carried out on dilute solutions in 12-mm Kel-F centerpiece centrifuge cells. A Spinco model E analytical ultracentrifuge equipped with an ultraviolet optical system was operated at 50,740 rev/min, and pictures were taken at 2-min intervals. The photographs were traced with a Joyce-Loebl Mark III B microdensitometer, and sedimentation coefficients (S5".) and distributions of sedimentation co-